The global #biosimilars_market is experiencing rapid expansion, driven by the growing demand for affordable biologic therapies and an increase in the prevalence of chronic diseases worldwide. According to market research, the sector is projected to rise significantly from USD 22.7 billion in 2025 to USD 68.4 billion by 2033, at a compelling compound annual growth rate (CAGR) of 15.3%.
Read More:
https://m2squareconsultancy.com/reports/global-biosimilars-market
Read More:
https://m2squareconsultancy.com/reports/global-biosimilars-market
The global #biosimilars_market is experiencing rapid expansion, driven by the growing demand for affordable biologic therapies and an increase in the prevalence of chronic diseases worldwide. According to market research, the sector is projected to rise significantly from USD 22.7 billion in 2025 to USD 68.4 billion by 2033, at a compelling compound annual growth rate (CAGR) of 15.3%.
Read More:
https://m2squareconsultancy.com/reports/global-biosimilars-market
·82 Просмотры
·0 предпросмотр